This measure assesses whether patients discharged from an inpatient psychiatric facility (IPF) with major depressive disorder (MDD), schizophrenia, or bipolar disorder filled a prescription for evidence-based medication within 2 days prior to discharge and 30 days post-discharge. This measure evaluates admissions over a two-year period.
The numerator for the measure includes: • Discharges with a principal diagnosis of MDD in the denominator population for which patients were dispensed evidence-based outpatient medication within 2 days prior to discharge through 30 days post-discharge • Discharges with a principal diagnosis of schizophrenia in the denominator population for which patients were dispensed evidence-based outpatient medication within 2 days prior to discharge through 30 days post-discharge • Discharges with a principal diagnosis of bipolar disorder in the denominator population for which patients were dispensed evidence-based outpatient medication within 2 days prior to discharge through 30 days post-discharge
Denominator
1.15 Denominator
The target population for this measure is Medicare fee-for-service (FFS) beneficiaries with Part D coverage aged 18 years and older discharged from an inpatient psychiatric facility with a principal diagnosis of MDD, schizophrenia, or bipolar disorder.
Exclusions
Exclusions
The denominator for this measure excludes discharged patients who: • Received electroconvulsive (ECT) during the inpatient stay or follow-up period • Received transcranial stimulation (TMS) during the inpatient stay or follow-up period • Were pregnant at discharge • Had a secondary diagnosis of delirium at discharge • Had a principal diagnosis of schizophrenia with a secondary diagnosis of dementia at discharge
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Behavioral Health and Substance Use Fall Cycle 2020
Public Comments